Dentsply Sirona (XRAY) said Tuesday it is planning to refocus its Byte business model and is assessing the go-to-market business and economic model.
The company said that in connection with the review, it won't reinstate the at-home Byte Aligner Systems and Impression Kits but will still support non-contraindicated Byte Aligner patients currently undergoing treatment.
Dentsply Sirona said it will continue to work with regulators and get any needed clearances before any market launch.
In October 2024, the company voluntarily suspended sales and marketing of its Byte Aligners and Impression Kits while it reviewed certain regulatory requirements related to the products.
Price: 18.75, Change: +0.09, Percent Change: +0.48
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。